Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions

참고문헌 (11)

1. Schaffner F, "Nonalcoholic fatty liver disease", Prog Liver Dis, 8, pp.283~298 (1986)
2. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
3. Younossi ZM, "The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe", Hepatology, 64, pp.1577~1586 (2016)
4. Adams LA, "The natural history of nonalcoholic fatty liver disease : a population-based cohort study", Gastroenterology, 129, pp.113~121 (2005)
5. Eslam M, "MAFLD : a consensus-driven proposed nomenclature for metabolic associated fatty liver disease", Gastroenterology, 158, pp.1999~2014 (2020)
6. Wong VW, "Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease", Clin Gastroenterol Hepatol, 19, pp.2161~2171 (2021)
7. Lee H, "Metabolic dysfunctionassociated fatty liver disease and incident cardiovascular disease risk : a nationwide cohort study", Clin Gastroenterol Hepatol, 19, pp.2138~2147 (2021)
8. Huang Shang-Chin, "Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease", Gut and Liver, 15(3), pp.451~458 (2021), 거트앤리버 소화기연관학회협의회[DOI]
9. Alexander M, "Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke : findings from matched cohort study of 18 million European adults", BMJ, 367, pp.l5367~ (2019)
10. Kim D, "Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States", J Hepatol, 75, pp.1284~1291 (2021)
11. Seogsong Jeong, "Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease", Gut and Liver, 16(4), pp.589~598 (2022), 거트앤리버 소화기연관학회협의회[DOI]

관련 논문AI추천